A detailed history of Kingswood Wealth Advisors, LLC transactions in Purple Biotech Ltd. stock. As of the latest transaction made, Kingswood Wealth Advisors, LLC holds 208,060 shares of PPBT stock, worth $85,304. This represents 0.01% of its overall portfolio holdings.

Number of Shares
208,060
Previous 186,100 11.8%
Holding current value
$85,304
Previous $125 Million 32.09%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$0.41 - $0.86 $9,003 - $18,885
21,960 Added 11.8%
208,060 $84.7 Million
Q1 2024

Apr 15, 2024

BUY
$0.58 - $0.92 $6,380 - $10,120
11,000 Added 6.28%
186,100 $125 Million
Q4 2023

Jan 16, 2024

BUY
$0.78 - $1.67 $34,671 - $74,231
44,450 Added 34.02%
175,100 $137 Million
Q3 2023

Oct 23, 2023

BUY
$1.02 - $1.49 $2,754 - $4,023
2,700 Added 2.11%
130,650 $140 Million
Q2 2023

Aug 09, 2023

BUY
$1.38 - $2.05 $176,571 - $262,297
127,950 New
127,950 $178 Million

Others Institutions Holding PPBT

About PURPLE BIOTECH LTD.


  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $7.5M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Kingswood Wealth Advisors, LLC Portfolio

Follow Kingswood Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingswood Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingswood Wealth Advisors, LLC with notifications on news.